Piper Sandler
Biren Amin is a seasoned financial executive and strategist in the biotech sector, currently serving as Managing Director at Piper Sandler since March 2024 and as a Member of the Board of Trustees for The Axiom REACH Foundation since April 2022. With a focus on public health disparities, Axiom REACH supports underserved communities facing critical health challenges. Previously, Biren held key positions including Chief Financial Officer at Pyramid Biosciences, which was acquired by Biohaven Pharmaceuticals, and Chief Financial Officer at Immuneering Corporation, where a successful IPO led to a $120 million offering. Biren's extensive experience includes equity research roles at Jefferies and other firms, complemented by degrees from NYU Stern School of Business, Long Island University, and the University of the Sciences in Philadelphia.
This person is not in any teams
This person is not in any offices
Piper Sandler
8 followers
Piper Sandler Companies (NYSE: PIPR) is a leading investment bank and institutional securities firm driven to help clients Realize the Power of Partnership®. Securities brokerage and investment banking services are offered in the U.S. through Piper Sandler & Co., member SIPC and NYSE; in Europe through Piper Sandler Ltd., authorized and regulated by the U.K. Financial Conduct Authority; and in Hong Kong through Piper Sandler Hong Kong Limited, authorized and regulated by the Securities and Futures Commission. Asset management products and services are offered through separate investment advisory affiliates.